Alpha Teknova, Inc.
NASDAQ: TKNO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Stephen Gunstream
- Employees
- 173
- Headquarters
- Hollister, United States
- IPO year
- 2021
- Market cap
- $278.8M
- Website
- https://www.teknova.com
Loading TKNO…
Loading profile data…Frequently asked questions about TKNO
What does Alpha Teknova, Inc. (TKNO) do?
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnosti...
Where does TKNO trade?
Alpha Teknova, Inc. (TKNO) trades on the NASDAQ Global Market.
What sector is TKNO in?
Alpha Teknova, Inc. (TKNO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Alpha Teknova, Inc.?
Stephen Gunstream is the chief executive officer of Alpha Teknova, Inc. (TKNO).
Where is Alpha Teknova, Inc. headquartered?
Alpha Teknova, Inc. is headquartered in United States.
Does TKNO pay a dividend?
Alpha Teknova, Inc. (TKNO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TKNO go public?
Alpha Teknova, Inc. (TKNO) completed its initial public offering in 2021.